Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Depreciation & Amortization (CF): 2020-2024

Historic Depreciation & Amortization (CF) for Cullinan Therapeutics (CGEM) over the last 5 years, with Dec 2024 value amounting to $306,000.

  • Cullinan Therapeutics' Depreciation & Amortization (CF) rose 30.51% to $77,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $310,000, marking a year-over-year increase of 233.33%. This contributed to the annual value of $306,000 for FY2024, which is 1.29% down from last year.
  • Per Cullinan Therapeutics' latest filing, its Depreciation & Amortization (CF) stood at $306,000 for FY2024, which was down 1.29% from $310,000 recorded in FY2023.
  • In the past 5 years, Cullinan Therapeutics' Depreciation & Amortization (CF) ranged from a high of $310,000 in FY2023 and a low of $53,000 during FY2021.
  • Its 3-year average for Depreciation & Amortization (CF) is $236,333, with a median of $306,000 in 2024.
  • In the last 5 years, Cullinan Therapeutics' Depreciation & Amortization (CF) fell by 14.52% in 2021 and then skyrocketed by 233.33% in 2023.
  • Cullinan Therapeutics' Depreciation & Amortization (CF) (Yearly) stood at $62,000 in 2020, then dropped by 14.52% to $53,000 in 2021, then surged by 75.47% to $93,000 in 2022, then surged by 233.33% to $310,000 in 2023, then declined by 1.29% to $306,000 in 2024.